| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105656 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105649 Gene and amplification with polynucleotides having amino acid sequence |
| 09/12/2006 | US7105648 Oligomers substituted by phosphite acid ester, phosphonic acid or carbaborane functions and the corresponding PNA monomers |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105576 Synergistic effects of nuclear transcription factor NF-κB inhibitors and anti-neoplastic agents |
| 09/12/2006 | US7105575 Methods for the treatment of neuro- disorders using aminothiol compounds |
| 09/12/2006 | US7105560 Use of etodolac in the treatment of multiple myeloma |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105530 Pyrimidineamines as angiogenesis modulators |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105520 Alpha 4 integrin antagonists |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105518 Thiopyrane-4-ones as DNA protein kinase inhibitors |
| 09/12/2006 | US7105511 Fluorescent fused-ring triazoles that inhibit cell proliferation and uses thereof |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105501 Compositions with vascular damaging activity |
| 09/12/2006 | US7105492 Antitumor agents |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/12/2006 | US7105330 Immunoglobulin for detection and isolation of preferential glycosidase; tumor diagnosis and antitumor agents |
| 09/12/2006 | US7105229 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 09/12/2006 | US7105186 Triterpene compositions and methods for use thereof |
| 09/12/2006 | US7105162 Peptide or protein from a pathogenic or tumor agent having immunomodulatory activity with an adjuvant capable of increasing the binding of the peptide to the cells of the individual or increasing the entry of the peptide into the cells; strengthening immunomodulatory activity; polyamino acids adjuvants |
| 09/12/2006 | US7105157 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/12/2006 | US7105155 Method and activated lymphocyte preparations for preventing recurrence of carcinoma |
| 09/12/2006 | CA2346539C Compositions and methods for enhancing receptor-mediated cellular internalization |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2215069C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 09/12/2006 | CA2180730C Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094233A1 N,n'-dicyclic isothiourea sirtuin modulators |
| 09/08/2006 | WO2006093991A1 Compounds which bind psma and uses thereof |
| 09/08/2006 | WO2006093745A1 Purification of rapamycin |
| 09/08/2006 | WO2006093337A1 Preventive/therapeutic agent for cancer |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093291A1 19-norvitamin d derivative |
| 09/08/2006 | WO2006093267A1 Fermentation composition having immunomodulating effect |
| 09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006093205A1 Method and device for cell preparation |
| 09/08/2006 | WO2006092714A2 Inhibition of spag9 expression with sirnas |
| 09/08/2006 | WO2006092640A1 Antiproliferative peptides containing the motif phe-trp-leu, pharmaceutical compositions and medical uses thereof |
| 09/08/2006 | WO2006092574A1 Indolylamino quinazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092573A1 Indazolylamino qionazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092510A1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use |
| 09/08/2006 | WO2006092326A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors |
| 09/08/2006 | WO2006092313A1 Lipopeptides having pharmaceutical activity |
| 09/08/2006 | WO2006092230A2 Protein-binding camptothecin peptide derivatives and medicaments comprising the same |
| 09/08/2006 | WO2006092062A1 Methods for cancer prognosis |
| 09/08/2006 | WO2006092024A1 Compounds having anti-cancer properties |
| 09/08/2006 | WO2006092017A1 Glycoalkaloid and tlr agonist combinations and various uses thereof |
| 09/08/2006 | WO2006071548A3 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/08/2006 | WO2006029224A3 Methods of using death receptor ligands and cd20 antibodies |
| 09/08/2006 | WO2006029010A3 Methods of activating nkt cells |
| 09/08/2006 | WO2006021008A3 Ionophores as cancer chemotherapeutic agents |
| 09/08/2006 | WO2003028696A8 Compositions for delivery of drug combinations |
| 09/08/2006 | CA2600908A1 Methods for cancer prognosis |
| 09/08/2006 | CA2600118A1 Fermented compositions having immunomodulatory actions |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599875A1 Preventive/therapeutic agent for cancer |
| 09/08/2006 | CA2599864A1 Peptide-mimetics and use thereof as inhibitors of the 20s proteasome, 26s proteasome and the immunoproteasome |
| 09/08/2006 | CA2599582A1 Purification of rapamycin |
| 09/08/2006 | CA2599544A1 Novel aminopyridine compound with syk inhibitory activity |
| 09/08/2006 | CA2599424A1 Compounds having anti-cancer properties |
| 09/08/2006 | CA2599270A1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use |
| 09/07/2006 | WO2006078903B1 Radiosensitizer formulations comprising nitrohistidine derivatives |
| 09/07/2006 | US20060199962 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 09/07/2006 | US20060199946 Apoptosis inducing agent and method for inducing apoptosis |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199858 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/07/2006 | US20060199840 Chemical derivatives and their application as antitelomerase agent |
| 09/07/2006 | US20060199837 Substituted tetrahydro-1h-pyrazolo [3,4-c]pyridines compositions comprising them, and use |
| 09/07/2006 | US20060199835 Neuroprotective and anti-proliferative compounds |
| 09/07/2006 | US20060199831 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 09/07/2006 | US20060199830 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199820 e.g. N1-hydroxy-N2-[(4-phenoxyphenyl)sulfonyl]-D-argininamide; metallopeptidase inhibitor; antiinflammation, anticarcinogenic, antidiabetic agent; angiogenesis inhibitor; atherosclerosis, stroke, ulcer, infertility, scleroderma, endometriosis, mesothelioma |
| 09/07/2006 | US20060199819 Inhibition of cyclooxygenase-2 activity |
| 09/07/2006 | US20060199792 Peroxynitrite decomposition catalysts and methods of use thereof |
| 09/07/2006 | US20060199787 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/07/2006 | US20060199782 Gene therapy using a SYN3 and SYN3 homolog delivery enhancing agent with an interferon protein or an interferon gene delivery system; anticarcinogenic agents |
| 09/07/2006 | US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 09/07/2006 | US20060199179 Method for diagnosis of colorectal tumors |
| 09/07/2006 | US20060198898 Orally administering edible oil homogenized with an edible wax at a concentration ranging from 0.5% to 50% by weight and a sterol compound at a concentration of at least 0.1% by weight for repairing and promoting regeneration of mucosa in the GI tract |
| 09/07/2006 | US20060198846 Combinations for the treatment of diseases involving angiogenesis |
| 09/07/2006 | DE102006007309A1 Preparing temozolomide base, useful as antitumor agent, comprises preparing temozolomide hydrochloride and converting to temozolomide base in acidic medium |
| 09/07/2006 | DE102005010000A1 Indane Indanes |
| 09/07/2006 | DE102005009784A1 Peptid-Mimetika und ihre Verwendung als Inhibitoren des 20S Proteasoms, 26S Proteasoms und Immunoproteasoms Peptide mimetics and their use as inhibitors of the 20S proteasome, the 26S proteasome and immunoproteasome |
| 09/07/2006 | DE102005009440A1 Thienopyridinderivate Thienopyridine derivatives |
| 09/07/2006 | DE102005008797A1 Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung Trofosfamide-containing film-coated tablets and to processes for their preparation |
| 09/07/2006 | DE10038043B4 Phamakologisch wirksame Substanz zur Behandlung kardiovaskulärer Erkrankungen Of pharmacologically active substance for the treatment of cardiovascular diseases |